NO885269L - Proteinholdige sammensetninger. - Google Patents

Proteinholdige sammensetninger.

Info

Publication number
NO885269L
NO885269L NO88885269A NO885269A NO885269L NO 885269 L NO885269 L NO 885269L NO 88885269 A NO88885269 A NO 88885269A NO 885269 A NO885269 A NO 885269A NO 885269 L NO885269 L NO 885269L
Authority
NO
Norway
Prior art keywords
cells
protein
proteinaceous
composition according
growth
Prior art date
Application number
NO88885269A
Other languages
English (en)
Norwegian (no)
Other versions
NO885269D0 (no
Inventor
Hannah Farkas-Himsley
Geoffrey Wyatt Henson
Robert Charles Brooks
Original Assignee
Univ Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toronto filed Critical Univ Toronto
Publication of NO885269D0 publication Critical patent/NO885269D0/no
Publication of NO885269L publication Critical patent/NO885269L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO88885269A 1987-11-27 1988-11-25 Proteinholdige sammensetninger. NO885269L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12703287A 1987-11-27 1987-11-27

Publications (2)

Publication Number Publication Date
NO885269D0 NO885269D0 (no) 1988-11-25
NO885269L true NO885269L (no) 1989-05-29

Family

ID=22427981

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885269A NO885269L (no) 1987-11-27 1988-11-25 Proteinholdige sammensetninger.

Country Status (8)

Country Link
EP (1) EP0318302A1 (fr)
JP (1) JPH01199594A (fr)
AU (1) AU2591588A (fr)
DK (1) DK661488D0 (fr)
FI (1) FI885486L (fr)
IL (1) IL88480A0 (fr)
MC (1) MC1989A1 (fr)
NO (1) NO885269L (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
EP0213811A3 (fr) * 1985-08-16 1987-09-09 Johnson Matthey, Inc., Composés dirigés par une bactériocine pour le traitement du cancer
IL82627A0 (en) * 1986-05-28 1987-11-30 Univ Toronto Bacteriocins and compositions thereof in anti-viral treatment

Also Published As

Publication number Publication date
IL88480A0 (en) 1989-06-30
NO885269D0 (no) 1988-11-25
DK661488D0 (da) 1988-11-25
AU2591588A (en) 1989-09-07
FI885486A7 (fi) 1989-05-28
EP0318302A1 (fr) 1989-05-31
JPH01199594A (ja) 1989-08-10
FI885486L (fi) 1989-05-28
MC1989A1 (fr) 1989-11-30
FI885486A0 (fi) 1988-11-25

Similar Documents

Publication Publication Date Title
JP6040212B2 (ja) 組換えマンネンタケ(Ganodermalucidium)免疫調節タンパク質(rLZ−8)およびその使用
JPH07503851A (ja) 改良インターフェロン及びヒトの末梢血液白血球からのその製造方法
CN101182350A (zh) 金黄色葡萄球菌α-溶血素及其编码序列
CN101245110A (zh) 重组白细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
EP0132125A2 (fr) Protéine ayant une activité antitumorale
US4861754A (en) Bacteriocins and compositions thereof in anti-viral treatment
KR920002935B1 (ko) 맥관 형성 저해제
RU2198178C2 (ru) Пептид-иммунорегулятор (варианты), лекарственное средство, включающее пептид-иммунорегулятор
Rosenbaum et al. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
NO885269L (no) Proteinholdige sammensetninger.
CN117285605A (zh) 可阻断腺苷-a2ar通路的蛋白及其应用
NO872223L (no) Bakteriociner og preparater inneholdende disse for antivirusbehandling.
CN110237235B (zh) 华支睾吸虫重组蛋白CsHscB在胆汁淤积性肝纤维化治疗药物中的应用
Wang et al. Antibacterial activities of antibacterial proteins/peptides isolated from organs and mucus of Clarias gariepinus reared at high stocking density
JP4604240B2 (ja) 光阻害免疫能力回復剤及びその製造方法
EP0134247A1 (fr) Proteine a effet oncostatique, son procede de preparation et mediament oncostatique la contenant
JPH03505449A (ja) 膜翅目昆虫毒、タンパク様あるいはポリペプチド成分、あるいはタンパク様あるいはポリペプチド成分のアナログを含む薬剤を用いた、哺乳類の感染症の処置に用いる方法および組成物
CN110064052A (zh) 一种英国梧桐花粉变应原浸提物、其浸液及其制备方法
NO850152L (no) Fremgangsmaate ved fremstilling av human, endogen cancerregulerende faktor.
Grójec et al. Staphylococcal leukocidin, Panton-Valentine type
Saim et al. Low molecular weight immunosuppressive factors found in elevated amounts in cancer ascitic fluids of mice 1. Isolation, identification and immunosuppressive effects of uric acid and uracil
CN114469928A (zh) 木犀草素在制备抑制化脓性链球菌溶血素功能活性的药物中的应用
CA2454345A1 (fr) Activite antitumorale utilisant le serum de reptiles
JP4224808B2 (ja) 生理活性物質
Ninnemann et al. Circulating toxins in human disease: a viable concept?